Immobilization of biotinylated bacteriophages on biosensor surfaces

https://doi.org/10.1016/j.snb.2007.03.007Get rights and content

Abstract

Bacteriophages are viruses that recognize specific receptors on the bacterium surface to which they bind and inject genetic material. The specificity of this recognition opens remarkable possibilities for biosensor development. The chemical attachment of T4 bacteriophages onto gold surfaces is being reported. This attachment leverages the genetic biotinylation of the capsid heads of bacteriophages, and the natural affinity of the biotin/streptavidin system. The development of a streptavidin-immobilization chemistry that minimizes non-specific binding of the target bacterium is first described. The attachment of genetically biotinylated T4 bacteriophages onto these streptavidin-coated surfaces is then reported. Such chemical immobilization results in a 15-fold improvement of attachment when compared to the simple physisorption of the wild-type phage onto bare gold. The attachment procedure was then used to investigate the effect of a biotinylated phage-terminated surface on the growth of the host bacteria. This assessment was conducted in an electric cell-substrate impedance sensing device. The streptavidin-mediated attachment of biotinylated phages significantly delays the growth of the host bacteria by up to 17.2 h. In comparison, non-specific binding of wild-type phages onto the streptavidin surface is found to cause a lesser growth delay of 13 h.

Introduction

Increasing public health concerns related to bacterial diseases, as well as the need to monitor food and water supplies have prompted interest in the development of low-cost and low-footprint pathogen detection systems. The detection and identification of pathogens in food products, drinking water supplies and hospitals continue to mostly rely on conventional microbiological culture techniques. These tests are based on assessing a bacterium's ability to grow in plates or tubes containing a variety of media (solid or liquid) under various conditions. While detection of a small number of bacteria is possible by incubation, growth of bacteria to numbers sufficient for identification can take several days. In addition, further biochemical and serological tests are required to confirm the identity of the agent.

Polymerase chain reaction (PCR) may also be used to amplify a small amount of genetic material from bacteria [1], [2]. Alternatively, bacterial identification using enzyme-linked immunosorbent assay (ELISA) is conducted by testing antibody–antigen interaction with the targeted bacterium and can be performed within a working day [3]. Combined PCR-ELISA increases sensitivity of the conventional PCR method [4], [5]. However, these techniques still require an enrichment step during which bacteria are grown to the levels required for detection. In addition, problems associated with enzyme inhibition and DNA extraction have made direct detection of low numbers of bacteria in foods by PCR difficult to achieve.

Therefore, there has been sustained interest towards the development of biosensing systems that would circumvent the limitations of conventional techniques. A typical biosensor platform couples a physical transducer (electrochemical, mechanical, thermal, or optical) with a specific recognition probe such as an enzyme, nucleic acid, cell, antibody or artificial receptor. The interaction between the probe and the target is converted to a quantifiable signal by the transducer. Micromechanical resonators [6], [7], quartz crystal microbalances (QCM) [8], [9], [10], surface plasmon resonance (SPR) [11], [12], [13], [14], [15], and amperometry [16] have been demonstrated as potent platforms for such applications. For example, Salmonella has been detected by immobilizing polyclonal antibodies on a quartz crystal acoustic wave device using Langmuir–Blodgett films [17]. Another example includes the use of SPR to effectively detect Escherichia coli bacteria [18]. The development of these technologies as viable biosensing systems requires the use of a recognition probe offering high levels of specificity, selectivity, and stability. Antibodies are frequently used as recognition receptor systems for the specific detection of antigens. While antibodies may offer some degree of selectivity and speficity (especially monoclonal antibodies), they suffer from environmental instabilities and require arduous and cost-intensive methods for their production, isolation and purification. In addition, polyclonal antobodies are limited by their heterogenicity towards other species, strains or molecules. Thus, there is a need for alternative probe selection [19], [20].

Bacteriophages (or phages) offer such potential as alternative probes for specific biosensing. They are viruses that recognize specific receptors on the bacterial surface to which they bind and inject their genetic material. Such injection allows replication of the phage and release of a new generation while killing the bacteria. These viruses recognize target bacteria through functional receptors located on their tail extremity (Fig. 1(a)) [21]. This recognition is routinely employed in phage typing where a group of phages are used to differentiate between different bacteria. This unique level of specificity also presents remarkable possibilities for biosensor development. For instance, the use of a lytic phage for the SPR detection of Staphylococcus aureus was recently reported [22]. However, the attachment of phages was accomplished by simple non-oriented physisorption of the viruses onto the sensor surface.

Alternatively, chemical attachment of phages onto sensor surfaces could significantly improve the stability and performance of the overall platform, and enable their employment in applications where patterning of the probing element is required. The chemical biotinylation of phages has already been shown to significantly increase the efficiency of phage-based biosorbents when compared to simple physical adsorption [23]. In the case of microsensors, bacteriophages bound from the head capsid protein onto the sensor surface would also allow the tail fibers to face the medium, enabling a more efficient capture of the bacteria.

The biotin–avidin complex has been used for binding purposes in previously reported bacterial sensing applications [24], [25]. Edgar et al. [26] has recently reported the genetic modification of the T7 bacteriophage to display a small peptide on the major capsid protein that is subsequently biotinylated by the biotin-ligase protein (BLP) present in the host bacterium. The biotin was attached postranslationally by the BLP to a specific lysine residue in the tagged peptide. Such genetic biotinylation opens the possibility of leveraging the affinity of the streptavidin/biotin system for the attachment of the phages onto particles and surfaces. In addition, as opposed to phages biotinylated by chemical procedures [23], the biotin is in these cases exclusively present on the phage capsid, and not on its tail, potentially allowing the oriented attachment of the phage onto surfaces.

We here describe such development of a surface attachment scheme that involves T4 bacteriophages that were similarly engineered to express a biotin binding domain on a capsid protein using a phage display technique. The constructed recombinant bacteriophage was reported to retain infectivity, burst size and latent period comparable to its wild-type counterpart. While the details of this biotinylation procedure is to be reported elsewhere [27], we here specifically report the streptavidin-mediated attachment of these recombinant biotinylated phages onto gold electrodes (Fig. 1(b)), as well as the use of this attachment in an impedance biosensing device (Fig. 1(c)). We observe that such streptavidin-mediated attachment of biotinylated phages improves by a factor of 15 the attachment of the viruses onto electrode surfaces, and significantly delays the growth of the host bacterium in comparison with electrodes functionalized using wild-type phages.

Such antibody-free chemical attachment of phages onto sensor surfaces could therefore be used in numerous other sensing transduction techniques, and enable the design of highly sensitive and highly specific platforms for the detection and identification of the host pathogenic organism.

Section snippets

Materials

1-Hexadecanethiol, 11-mercapto-1-undecanol, 11-mercapto-undecanoic acid, cysteamine hydrochloride and bovine serum albumin (BSA) were purchased from Sigma–Aldrich (St-Louis, MO, USA). Sulfosuccinimidyl-2-(biotinamido)-ethyl-1,3-dithiopropionate (sulfo-NHS-SS-biotin), tetramethyl rhodamine isothiocyanate (TRITC)-conjugated streptavidin and BupH phosphate buffered saline packs were purchased from Pierce (Rockford, IL, USA). E. coli was labeled using the SYTO BC bacteria stain from a bacteria

Results and discussion

Fig. 2(b) shows the fluorescent microscopy data of the seven gold samples following exposure to TRITC-streptavidin and SYTO BC E. coli solutions, respectively. Relative intensity of streptavidin fluorescence as well as bacterial count for each of the seven samples, are plotted. Streptavidin and E coli. adsorb readily to bare gold (sample G), demonstrating the need of surface chemistry to prevent non-specific adsorption. Hexadecanethiol treated with BSA (sample B) resulted in minimal E. coli

Conclusions

We reported the streptavidin-mediated attachment of capsid-biotinylated phages onto gold electrodes, as well as the employment of such an attachment in an impedance biosensing system. The functionalization of gold surfaces with a biotin-terminated alkyl chain optimizes the attachment of streptavidin while minimizing the non-specific adsorption of the host E. coli. These streptavidin-fuctionalized surfaces were then used to capture bacteriophages with biotinylated capsid heads. The capture

Acknowledgments

This work was supported by the National Institute for Nanotechnology (NINT), a joint venture between the National Research Council of Canada, the University of Alberta and the province of Alberta. The SEM imaging of the bacterial phage-coated surfaces was performed at the NINT Electron Microscopy facilities. Fabrication of gold substrates was undertaken in the University of Alberta Nanofab facilities. The authors would like to thank Dr. Ken Westra and the Nanofab staff for valuable discussions

Luc Gervais received his Bachelor of Engineering degree in Computer Engineering in 2004 from Concordia University in Montreal. After a year at National Taiwan University, where he learned the intricacies of the Chinese language, he is currently pursuing a Masters of Science in Electrical and Computer Engineering at the University of Alberta. His interests are the integration of biological and electronic systems, bionanotechnology, and bioMEMS sensors and devices used in medical diagnostics.

References (28)

  • Y. Hong et al.

    Rapid detection of Campylobacter coli, C. jejuni, and Salmonella enterica on poultry carcasses by using PCR-enzyme-linked immunosorbent assay

    Appl. Environ. Microbiol.

    (2003)
  • M. Jones et al.

    PCR-ELISA for the early diagnosis of invasive pulmonary aspergillus infection in neutropenic patients

    J. Clin. Pathol.

    (1998)
  • B. Ilic et al.

    Single cell detection with micromechanical oscillators

    J. Vac. Sci. Technol. B

    (2001)
  • B. Ilic et al.

    Virus detection using nanoelectromechanical devices

    Appl. Phys. Lett.

    (2004)
  • Cited by (116)

    • Self-assembled monolayer-based nanoscaled surfaces

      2023, Biophysics at the Nanoscale: Applications of Functional Materials
    • Atomic layer deposition for biosensing applications

      2018, Biosensors and Bioelectronics
    View all citing articles on Scopus

    Luc Gervais received his Bachelor of Engineering degree in Computer Engineering in 2004 from Concordia University in Montreal. After a year at National Taiwan University, where he learned the intricacies of the Chinese language, he is currently pursuing a Masters of Science in Electrical and Computer Engineering at the University of Alberta. His interests are the integration of biological and electronic systems, bionanotechnology, and bioMEMS sensors and devices used in medical diagnostics.

    Murat Gel received his BS degree in Physics from Middle East Technical University, Turkey in 1997. He received MS and PhD degrees in Mechano-Informatics from the University of Tokyo, Japan in 2000 and 2003, respectively. He worked as a Researcher in the Center for International Research on MicroMechatronics in Tokyo (2003–2005), also, he worked as Postdoctoral Fellow in National Institute for Nanotechnology, Canada (2005–2006). His research interests include the development of microfabricated cantilevers for sensitive force measurements as well as the biofunctionalization of these devices for biosensing applications. Dr. Gel is also interested in applications of MEMS-based tools for single-molecule and single-cell level studies.

    Beatrice Allain obtained her PhD in Virology from the University of Lyon in 1994, studying the DNA replication of HIV virus. During her post-doctorate at the University of Montreal, she specialized in HIV protein expression by looking at the importance of accessory proteins in the viral replication. Then she joined the Biophage research team in 1999 as a Research Scientist to work on bacteriophages. She is now Director of the Therapeutic Division at Biophage Parma Inc. where she is developing an integrated approach for the management of bacterial contamination comprising the selection of phages for use in detection tools (biosensors) and as therapeutic agents (phage therapy). She has also developed complementary assays for bacterial detection based on impedance biosensors. These biosensors can be used alone or in conjunction with phage therapy for intelligent treatments. She is also author of numerous papers, presentations and patents.

    Mona Tolba graduated in 1998 from the Faculty of Veterinary Medicine, Cairo University, Egypt with a PhD in Veterinary Science. She was then Lecturer for a Food Microbiology course for Department of Food Hygiene, Faculty of Veterinary Medicine, Cairo University. Her initial Master and PhD work concentrated on the modeling growth, survival and control of Listeria moncytogenes in milk and dairy products. She immigrated to Canada in 2002 where she obtained a scholarship (2003) from the Department of Food science, University of Guelph to do another PhD. The focus of her PhD research is to develop site-specific immobilized bacteriophage for the detection and/or control of bacteria in food.

    Lubov Brovko obtained her degrees of PhD (1980) and DSc (1991) in Biochemistry and Biotechnology from Lomonosov Moscow State University, Moscow, Russia. She is currently a Senior Research Associate at Canadian Research Institute for Food Safety, and Adjunct Professor at the Department of Food Science, University of Guelph, Ontario, Canada. Dr. Brovko has published over 100 papers in peer-reviewed journals and 4 book chapters on basic mechanisms of bioluminescence and its applications in biochemistry, microbiology, immunology and biotechnology. Her current research projects include bioluminescent cell-based pathogenicity biosensors for high throughput assay, paper-based biosensors for pathogen detection, immuno-modulating properties of fermented milk and its components, antimicrobial photodynamic treatment for surface sanitation, and rapid phage-based methods for the detection pathogens in food. Dr. Brovko is a member and Scientific Advisor of International Society for Bioluminescence and Chemiluminescence. She recently submitted tutorial book on applications of bioluminescence for food and environmental safety for publication.

    Mohammed Zourob received his PhD in 2003 from Department of Instrumentation and Analytical Science (DIAS) from The University of Manchester Institute of Science and Technology (UMIST). From 2003–2005 Dr. Zourob worked as a Researcher at the University of Manchester working in biosensors and lab on a chip for life science applications. Then he moved to the Department of Biomaterials Science of the same university to work in developing high throughput screening platforms for “Omics” applications. At the end of 2005 Dr. Zourob moved to the Institute of Biotechnology at the University of Cambridge where his research focus on optical sensing and lab on a chip. Recently he was appointed as a Director of Biosensors Division at Biophage Pharma Inc. Dr. Zourob is currently editing a book “Technologies for the detection of bacteria (transducers, recognition receptors and microsystems)”. Dr. Zourob research interest includes the development of chemo/biosensors, highthroughput screening for “Omics” applications, platform for therasonstics applications, BioMEMS and lab on a chip for life sciences. He has a number of patents and many peer-reviewed articles. Dr. Zourob serving on the editorial board of a number of journals.

    Rosemonde Mandeville is an entrepreneur, a scientist and a seasoned manager, and the founder and acting president and CSO of Biophage Pharma Inc. She serves on several boards of directors, most importantly Investment Quebec. As a Former Professor, she has over 200 publications. Located at the National Research Council Biotechnology Research Institute (Montreal, Canada), Biophage employs 18 people, including a team of 14 researchers. Biophage has secured an impressive portfolio of promising new diagnostics and therapeutic applications of phages and possesses an extensive library of phages.

    Mansel Griffiths received his BSc degree in Applied Biology at North East London Polytechnic and his PhD from Leicester University where he studied the biochemistry of thermophilic microorganisms under the supervision of Sir Hans Kornberg. Dr. Griffiths was appointed to the staff of the Hannah Research Institute, Ayr, Scotland in 1974 and, in 1980, he was appointed Head of the Dairy Microbiology group. In 1990 Dr. Griffiths was appointed Chair in Dairy Microbiology in the Food Science Department at the University of Guelph. Dr. Griffiths’ position is funded jointly by the Dairy Farmers of Ontario and the Natural Science and Engineering Research Council of Canada (NSERC). Dr. Griffiths is Program Chair for the MSc in Food Safety and Quality Assurance programs being offered at Guelph and is the Director of the Canadian Research Institute for Food Safety. His current research interests include rapid detection of foodborne pathogens; factors controlling growth and survival of microorganisms in foods; beneficial uses of microorganisms. Dr. Griffiths has authored more than 250 peer-reviewed articles and appears on http://www.ISI HighlyCited.com.

    Stephane Evoy received a PhD in Applied Physics from Cornell University in 1998. He is an Assistant Professor of Electrical and Computer Engineering at the University of Alberta, with cross-appointment as Leader of the Devices and Sensors Group of the National Institute for Nanotechnology. His current research includes the development of micro/nanomechanical devices for biosensing applications, as well as the integration of nanostructures for the development of chemical sensors. Dr. Evoy has also recently co-edited “Introduction to Nanoscale Science and Engineering”, a textbook supporting the teaching of nanoscale technologies at the undergraduate level. He is currently serving as member of the Executive Committee of the Nanoscale Science and Technology Division of the American Vacuum Society. Since October of 2005, he is also serving on the editorial board of “Review of Scientific Instruments”.

    View full text